Publication:
Ulcerative Colitis and Thrombosis

Simple item page
dc.authorscopusid6701685009
dc.authorscopusid57197626318
dc.contributor.authorŞahan, C.
dc.contributor.authorÖztürk, M.
dc.date.accessioned2025-12-11T02:10:07Z
dc.date.issued2002
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Şahan] Cem, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkey,; [Öztürk] Murat, Zonguldak Bulent Ecevit University, Zonguldak, Zonguldak, Turkeyen_US
dc.description.abstractInflammatory bowel disease (IDB) is systemic disorder. An increased risk of arterial and venous thrombosis was originally reported by Borgen and Barker in 1936. Clinically, it is seen only 1-3% of patients admitted to the hospital for IBD. Ulcerative colitis may be complicated by macrovascular thrombosis. The most common manifestations are deep vein thrombosis of the leg and pulmonary emboli. Several mechanisms have been described which might explain an increased tendency for thromboembolic events in patients with IBD. Genetic risk factors for venous thrombosis are classified as deficiencies of protein C, protein S, antitrombin III, factor V leiden and protrombin 20210, hyperhomocysteinemia.en_US
dc.identifier.endpage290en_US
dc.identifier.issn1300-2996
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-0036961966
dc.identifier.scopusqualityN/A
dc.identifier.startpage287en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/47715
dc.identifier.volume19en_US
dc.identifier.wosqualityN/A
dc.language.isotren_US
dc.relation.ispartofOndokuz Mayis Üniversitesi Tıp Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHyperhomocysteinemiaen_US
dc.subjectThrombosisen_US
dc.subjectUlcerative Colitisen_US
dc.titleUlcerative Colitis and Thrombosisen_US
dc.title.alternativeÜlseratif Kolit ve Trombozen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu